Emlidus 10/5 mg is a prescription oral tablet produced by Opsonin Pharma Ltd. in Bangladesh. It combines two active ingredients: Empagliflozin (10 mg), a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, and Linagliptin (5 mg), a dipeptidyl peptidase-4 (DPP-4) inhibitor. This combination is used to improve glycemic control in adults with type 2 diabetes mellitus.